Enhancing clozapine management through finger prick testing
October 21, 2026
Clozapine is an important treatment option for patients with treatment-resistant schizophrenia (TRS), but its use requires regular monitoring of neutrophil counts.
On 21 October, we explored the role of point-of-care testing (POCT) in clozapine monitoring and how finger-prick testing may help improve patient adherence and treatment compliance.
Hannah Nauhaus, Global Product Manager, discussed the usability of the HemoCue WBC DIFF System in psychiatric care settings.
The webinar also featured a recorded presentation by Professor Jimmi Nielsen, Senior Consultant at the Department of Psychiatry, Glostrup Hospital, Denmark, and Professor at the University of Copenhagen. Professor Nielsen shared insights into clozapine management, clinical practice and the use of point-of-care blood monitoring.
If you missed the webinar, you can watch the recording Webinars - HemoCue.
Radiometer is using Microsoft AZURE Active Directory to authenticate users
Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.
If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.
Key benefits
- Allow the use of existing Active Directory credentials
- Single-sign on experience
- Use same credentials to access future services
Request access
You will receive an invitation to access our services via e-mail when your request has been approved.
When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.